CD274 and neoplasm: As anti-PD-1/PD-L1 effectiveness is influenced by PD-L1 status and tumor-infiltrating lymphocytes (TIL) [4], chemotherapy may enhance the release of tumor antigens and lymphocyte infiltration [2].